Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 1996

View Archived Issues

New macrocyclic immunosuppressants from Abbott

Nippon Kayaku R&D pipeline update

Company Profile: Progenitor, Inc.

Warner-Lambert claims lipid-regulating agents for vascular disease, diabetes

SKB reports D3-selective antipsychotic agents

Analgesic kappa-opioid agonists reported by Pfizer

New farnesyl protein transferase series synthesized at Merck & Co.

Fujisawa describes new agents for thrombocytopenia

FPTase inhibitior series reported by Schering-Plough

400-C, new FPTase inhibitor reported by Schering-Plough

Johns Hopkins University reports antiproliferative vitamin D3 analogue

Tanabe to develop marimastat

TBC-11251 enters clinical trials

Peripheral opiate antihyperalgesic from Adolor in clinical trials

Sanofi introduces new platinum complex

Potential of clotrimazole in the treatment of diarrhea

Pharming granted orphan drug status for Pompe's disease therapy

Pfizer's antiasthma drug R&D

Oculex dexamethasone intraocular delivery system superior to eye drops

Cel-Sci receives Japanese patent for HGP-30 technology

Xylitol chewing gum effective in preventing otitis media

Ansan starts new development program for chemotherapy-induced alopecia

HRT for preserving bone density in postmenopausal women

Immunoregulating effect of IL-4 in IDDM

Recombinant NOVOMAb-G2 as potential cancer diagnostic

Antimigraine drug from Vanguard to enter pivotal trials

First pivotal trial for panic disorder Rx

Cephalon/Leo neurological disease collaboration

LTB4-PPARalpha as a new target for drug design

Pharmadigm (formerly Paradigm Biosciences) reports progress on lead therapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...